ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,707.00
1.80 (0.11%)
Last Updated: 09:41:22
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.80 0.11% 1,707.00 1,707.00 1,707.40 1,708.60 1,699.40 1,701.60 418,076 09:41:22
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.25 70.23B

GlaxoSmithKline, Merck to Trial New Cancer Treatment

03/11/2015 1:00pm

Dow Jones News


Gsk (LSE:GSK)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Gsk Charts.

LONDON-- GlaxoSmithKline PLC (GSK.LN) said Tuesday that it and Merck & Co. Inc. (MRK) will trial a combination of two separate drugs as a potential cancer treatment.

The companies will commence human trails to evaluate Glaxo's investigational immunotherapy GSK3174998 as monotherapy in combination with Merck's anti-PD-1 therapy Keytruda in patients with tumors that have progressed after standard treatment.

Shares of Glaxo at 1227 GMT trading 0.04% lower at 1,397 pence.

 

Write to Tapan Panchal at tapan.panchal@wsj.com

 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


(END) Dow Jones Newswires

November 03, 2015 07:45 ET (12:45 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock